Anmeldung erfolgt in Kürze...
Details werden geladen...
High Court restrains NPPA from action against AstraZeneca - The Economic Times
The Delhi High Court has issued a temporary restraining order against the NPPA's actions toward AstraZeneca Pharma. This order remains in effect until the next hearing date, January 11. AstraZeneca has argued that its product may not fall under controlled drug prices. The NPPA has accused AstraZeneca of overcharging for the inhaler from May 2016 to November 2025. AstraZeneca denies these allegations and claims compliance with the price regulations.
Ähnliche Seiten
NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9 - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-caps-trade-margins-on-137-cancer-drugs-at-30-revised-prices-from-nov-9/articleshow/135015811.cms
‘Broad daylight dacoity’: Drug prices in six questions - The Times of India
https://timesofindia.indiatimes.com/toi-plus/health/broad-daylight-dacoity-drug-prices-in-six-questions/articleshow/134809788.cmsCancer drug price cuts leave costly brands untouched - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cancer-drug-price-cuts-leave-costly-brands-untouched/articleshow/135244832.cms
Centre Caps Cancer Drug Trade Margins At 30 Per Cent, Supreme Court Questions High Prices Of Other Medicines
https://www.freepressjournal.in/india/centre-caps-cancer-drug-trade-margins-at-30-per-cent-supreme-court-questions-high-prices-of-other-medicinesNPPA list brings little relief: No price cut for 25% cancer drugs - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-list-brings-little-relief-no-price-cut-for-25-cancer-drugs/articleshow/135338896.cms